Ronald W. McClurg insider trades
Open-market stock purchases and sales by Ronald W. McClurg, Chief Financial Officer at NEUROONE MEDICAL TECHNOLOGIES Corp, from SEC Form 4 filings since Jan 1, 2021.
Track record: 100% of 6 scored buys are up 5% or more since purchase, averaging +88%.
Recent trades
No open-market trades in the last 12 months.